Hanmi Pharm Group has announced a surprise merger with OCI Group in a deal that would place the leading South Korean pharmaceutical firm, with a portfolio including consumer health products, under the wing of the large compatriot energy and chemical enterprise.
Hanmi expects the move to help secure the investment it needs to grow into a truly global biopharma operation
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?